NSE · GUJTHEM
Gujarat Themis Biosyn Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#895
of 5,096 stocks
▼ 261W
Peak #869 · 21 Sep 2026
A smallcap name in Healthcare, Gujarat Themis Biosyn Limited carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 71%, and is growing revenue modestly.
Market Cap
4,331.90 Cr
P/E Ratio
92.89
P/B Ratio
15.05
ROE
16.22%
ROCE
15.33%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 43.79 Cr | 44.23 Cr | 43.37 Cr | 42.35 Cr |
| Net Profit | 11.07 Cr | 10.89 Cr | 12.46 Cr | 14.27 Cr |
| EPS | 1.02 | 1.00 | 1.14 | 1.31 |
| Operating Profit | 16.95 Cr | 16.24 Cr | 17.83 Cr | 18.80 Cr |
Shareholding pattern
Promoter
70.86%
Public
29.14%
Mutual fund holdings
₹172.34
Cr total
10
Schemes
5
Fund Houses
₹172.34 Cr
Total Exposure
Bank of India Mutual Fund₹89.45 Cr (51.9%)
Quant Mutual Fund₹52.94 Cr (30.7%)
Samco Mutual Fund₹29.82 Cr (17.3%)
Quantum Mutual Fund₹0.09 Cr (0.1%)
Motilal Oswal Mutual Fund₹0.04 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Sep 2025 | Dividend | Dividend - Re 0.67 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.